March 5, 2018 / 9:06 AM / 3 months ago

BRIEF-Recipharm Signs Licensing Agreement with Altus Formulation

March 5 (Reuters) - RECIPHARM AB (PUBL):

* RECIPHARM AND ALTUS FORMULATION COLLABORATE TO OFFER NOVEL DRUG DELIVERY TECHNOLOGIES FOR VALUE ADDED MEDICINES

* ‍HAS SIGNED A LICENSING AGREEMENT WITH ALTUS FORMULATION INC​

* ‍SIGNED A LICENSING AGREEMENT WITH ALTUS FORMULATION INC.​

* ‍ WILL CO-DEVELOP NEW VALUE ADDED MEDICINES FOR ITS CUSTOMERS UTILISING ALTUS’ PATENTED INTELLITAB™ AND FLEXITAB™ DRUG DELIVERY TECHNOLOGIES.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below